Carla H van Gils
Overview
Explore the profile of Carla H van Gils including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
249
Citations
7160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song C, Ahmad Bustamam R, Gin Gin G, Saad M, Abdul Satar N, Ramasamy A, et al.
Cureus
. 2024 Dec;
16(11):e73528.
PMID: 39669806
Introduction: There is a lack of real-world evidence on direct comparisons between COVID-19 vaccines in multiethnic low- and middle-income settings. Cancer patients have an impaired vaccine response due to the...
2.
ODriscoll J, Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, et al.
Breast Cancer Res
. 2024 Oct;
26(1):139.
PMID: 39350230
Background: Elevated mammographic density (MD) for a woman's age and body mass index (BMI) is an established breast cancer risk factor. The relationship of parity, age at first birth, and...
3.
Verdiesen R, von Berg J, Said M, van der Harst P, Mahajan A, van Gils C, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(8):269.
PMID: 39076620
Background: Higher age-specific circulating anti-Müllerian hormone (AMH) levels have been linked to a lower risk of cardiometabolic outcomes. However, whether AMH has a casual role in the etiology of these...
4.
Yang X, Mooij T, Leslie G, Ficorella L, Andrieu N, Kast K, et al.
J Med Genet
. 2024 Jun;
61(8):803-809.
PMID: 38834293
Background: No validation has been conducted for the BOADICEA multifactorial breast cancer risk prediction model specifically in pathogenic variant (PV) carriers to date. Here, we evaluated the performance of BOADICEA...
5.
den Dekker B, Broeders M, Meeuwis C, Setz-Pels W, Venmans A, van Gils C, et al.
Insights Imaging
. 2024 May;
15(1):131.
PMID: 38816526
Objective: To evaluate the diagnostic accuracy of supplemental 3D automated breast ultrasound (ABUS) in the diagnostic work-up of BI-RADS 0 recalls. We hypothesized that 3D ABUS may reduce the benign...
6.
Veenhuizen S, van Grinsven S, Laseur I, Bakker M, Monninkhof E, de Lange S, et al.
Eur Radiol
. 2024 Apr;
34(10):6334-6347.
PMID: 38639912
Objectives: Supplemental MRI screening improves early breast cancer detection and reduces interval cancers in women with extremely dense breasts in a cost-effective way. Recently, the European Society of Breast Imaging...
7.
Wang H, H M van der Velden B, Verburg E, Bakker M, Pijnappel R, Veldhuis W, et al.
Eur J Radiol
. 2024 Apr;
175:111442.
PMID: 38583349
Objectives: Background parenchymal enhancement (BPE) on dynamic contrast-enhanced MRI (DCE-MRI) as rated by radiologists is subject to inter- and intrareader variability. We aim to automate BPE category from DCE-MRI. Methods:...
8.
van Beers M, Speksnijder C, van Gils C, Frederix G, Dankbaar J, de Bree R
BMC Cancer
. 2024 Jan;
24(1):76.
PMID: 38225572
Background: Total laryngectomy (TL) is a surgical procedure commonly performed on patients with advanced laryngeal or hypopharyngeal carcinoma. One of the most common postoperative complications following TL is the development...
9.
Schaeffers A, Devriese L, van Gils C, Dankbaar J, Voortman J, de Boer J, et al.
PLoS One
. 2023 Nov;
18(11):e0294147.
PMID: 38011186
Chemoradiotherapy with cisplatin in a triweekly regimen of 100 mg/m2 body surface area, is used to treat locally advanced head and neck squamous cell carcinoma (HNSCC) with curative intent. Cisplatin...
10.
Eijkelboom A, de Munck L, Larsen M, Bijlsma M, Tjan-Heijnen V, van Gils C, et al.
Cancer Epidemiol
. 2023 Oct;
87:102481.
PMID: 37897970
Background: Comparing the impact of the COVID-19 pandemic on the incidence of newly diagnosed breast tumors and their tumor stage between the Netherlands and Norway will help us understand the...